HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 |
What is the latest Earnings Per Share (EPS) of HIKAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹5.64 |
| Mar2024 | ₹6.36 |
| Mar2023 | ₹13.02 |
| Mar2022 | ₹10.80 |
| Mar2021 | ₹6.85 |
How is Earnings Per Share (EPS) of HIKAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.64 | -11.32 | |
| Mar2024 | ₹6.36 | -51.15 | |
| Mar2023 | ₹13.02 | 20.56 | |
| Mar2022 | ₹10.80 | 57.66 | |
| Mar2021 | ₹6.85 | - | |
Compare Earnings Per Share (EPS) of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,491.9 Cr | -3.6% | 1.1% | -40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.6% |
1.1% |
-40.9% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses